Agricultural Inputs

• Name:
• Trailing PE:
• Forward PE:
• Price Sales TTM:
• Price Book MRQ:
• Enterprise Value Revenue:
• Enterprise Value Ebitda:

Orpheus Uranium Limited, through its subsidiaries, engages in the exploration and development of mineral properties. The company explores for uranium, copper, gold, nickel, lithium, and zinc deposits. It holds interests in the Frome project located in the Frome Embayment of South Australia; the Mundaerno/Woolshed project situated in the Frome Embayment and the overlying Callabonna sub-basin of South Australia; and the Radium Hill South project located in the historic Radium Hill Uranium Field in South Australia. The company also holds interests in the Marree project located in Murray Basin, South Australia; and the Mount Douglas project located in Pine Creek, Northern Territory. In addition, it holds interests in the Woolner, Ranger Northeast, and T-Bone tenements located in Pine Creek Oregon, Northern Territory; the Murdie, Torrens, Higginsville, and Kroombit assets situated in South Australia, Western Australia Queenslandy; and the Aroona project located in South Australia. The company was formerly known as Argonaut Resources NL and changed its name to Orpheus Uranium Limited in February 2024. Orpheus Uranium Limited was incorporated in 1985 and is based in Unley, Australia. Address: 79 King William Road, Unley, SA, Australia, 5061

• Name:
• Trailing PE:
• Forward PE:
• Price Sales TTM:
• Price Book MRQ:
• Enterprise Value Revenue:
• Enterprise Value Ebitda:

Neometals Ltd engages in the development and commercialisation of sustainable processing solutions that recycle and recover critical materials from waste streams in Australia. The company operates through three segments: Lithium, Titanium/Vanadium, and Other. Its projects include the Lithium-ion Battery Recycling project; Lithium Chemicals project; Vanadium Recovery project, which produces vanadium pentoxide from steelmaking by-products; and Barrambie Titanium and Vanadium project located in Western Australia. Neometals Ltd was incorporated in 2001 and is based in West Perth, Australia. Address: 1292 Hay Street, West Perth, WA, Australia, 6005

• Name:
• Trailing PE:
• Forward PE:
• Price Sales TTM:
• Price Book MRQ:
• Enterprise Value Revenue:
• Enterprise Value Ebitda:

Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand, the United States, Canada, Europe, Asia, and internationally. The company operates through three segments: Women's Health, Dermatology, and International. It provides oral drug delivery systems; and contract development and manufacturing services to third-party customers, as well as distributes specialty pharmaceutical products in the dermatology, women's health, and infectious disease therapeutic areas. The company was formerly known as Halcygen Pharmaceuticals Limited and changed its name to Mayne Pharma Group Limited in November 2010. Mayne Pharma Group Limited was incorporated in 2005 and is based in Salisbury South, Australia. Address: 1538 Main North Road, Salisbury South, SA, Australia, 5106

• Name:
• Trailing PE:
• Forward PE:
• Price Sales TTM:
• Price Book MRQ:
• Enterprise Value Revenue:
• Enterprise Value Ebitda:

Kingsrose Mining Limited, together with its subsidiaries, operates as an mineral exploration company in Norway and Finland. It explores for platinum group elements, nickel, copper, gold, cobalt, and palladium deposits. The company was incorporated in 2005 and is based in Nedlands, Australia. Address: 145 Stirling Highway, Nedlands, WA, Australia, 6009

• Name:
• Trailing PE:
• Forward PE:
• Price Sales TTM:
• Price Book MRQ:
• Enterprise Value Revenue:
• Enterprise Value Ebitda:

Juno Minerals Limited, an independent mining company, engages in the evaluation and development of mineral properties in Australia. The company explores for iron ore and lithium deposits. It holds interests in the Central Yilgarn Iron Project comprising the Mount Mason DSO hematite and Mount Ida magnetite projects covering approximately 490 square kilometers located near the northwest of the town of Menzies, Western Australia. The company was incorporated in 2020 and is based in North Perth, Australia. Address: 2A/300 Fitzgerald Street, North Perth, WA, Australia, 6006

• Name:
• Trailing PE:
• Forward PE:
• Price Sales TTM:
• Price Book MRQ:
• Enterprise Value Revenue:
• Enterprise Value Ebitda:

Immutep Limited, a late-stage biotechnology company, engages in developing novel LAG-3 related immunotherapies for cancer and autoimmune diseases in Australia. Its lead product candidate is the eftilagimod alpha (efti or IMP321), a soluble LAG-3lg fusion based, which is in clinical development for the treatment of different types of cancers. The company's product pipeline also includes TACTI-004, which is in phase III clinical trial for the treatment of first line non-small cell lung cancer (1L NSCLC); TACTI-003, which is in phase IIb clinical trial to treat first line head and neck squamous cell carcinoma (HNSCC); TACTI-002, which in phase II trial for the treatment NSCLC and HNSCC; AIPAC-003, which is in phase II/III clinical trial to treat metatastic breast cancer; and EFTISARC-NEO, which is in phase II clinical trial for the treatment of soft tissue sarcoma. In addition, it develops INSIGHT-003, which is in phase I to treat 1L NSCLC and solid tumors; INSIGHT-005, which is in phase I to treat metastatic urothelial cancer; IMP761, which is in preclinical trial to treat autoimmune disease; and IMP731 and IMP701 which is in clinical development. Further, the company develops LAG525, which is in phase II clinical trial to treat solid tumors and blood cancer, triple negative breast cancer, and melanoma; and in phase I to treat triple negative breast cancer. Immutep has collaboration with Merck & Co., Inc., GlaxoSmithKline, EOC Pharma, Novartis, and Laboratory Corporation of America Holdings. The company was formerly known as Prima BioMed Ltd and changed its name to Immutep Limited in November 2017. The company was incorporated in 1987 and is based in Sydney, Australia. Address: Australia Square, Sydney, NSW, Australia, 2000

• Name:
• Trailing PE:
• Forward PE:
• Price Sales TTM:
• Price Book MRQ:
• Enterprise Value Revenue:
• Enterprise Value Ebitda:

Hillgrove Resources Limited operates as a mining company in Australia. It explores for copper, gold, and silver deposits. The company's flagship project is Kanmantoo Copper mine located approximately 55 kilometres from Adelaide, South Australia. Hillgrove Resources Limited was incorporated in 1952 and is headquartered in Unley, Australia. Address: 5-7 King William Road, Unley, SA, Australia, 5061